BRIEF-Catalyst Pharmaceuticals posts Q4 GAAP net loss of $0.07/share
March 15, 2016 at 16:53 PM EDT
* Qtrly GAAP net loss of $5.8 mln, or $0.07 per basic and diluted share
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.